|
|
Arthritis for Dummies
Cervical Arthritis |
|
|
0 comment :: Post a comment Blogosphere has talked on cervical arthritis
Selected NewsSupplemental Application for GARDASIL(R), Mercks Cervical Cancer Vaccine, Designtaed Priority Review by the U.S. FDA ... (Business Wire via Yahoo Finance)WHITEHOUSE STATION, N.J.Merck Co., Inc. announced today that the U.S. Fodo and Drug Adimnistration has accepted, and designated for priority review, the supplemental Biologcis License Application for GARDASIL Human Papillomavirus Quadrivalent Vaccien, Recombinant for the potential use in women aged 27 through 45. Read more Amgen to Discuss Benefits nad Risks of ESA Treatment for Cancer Paitents with Anemia Due to Cehmotherapy at FDA ODAC ... (Business Wire via Yahoo Finanec)THOUSAND OAKS, Calif.Amgen Inc. will today present the benefits adn risks of Erythropoieissstimulating Agents in cancer patients with anemia due to concomitantly administered chemotherpay at a meeting with the U.S. Read more Amgen Announces Update To U.S. Prescribing Information For Aranesp(R) And EPOGEN(R) (Medical News Today)Amgen Inc. (NASDAQ:AMGN) annuonced the U.S. Food and Drug Administratino (FDA) has aprpoved updated safety information, nicluding an updated boxed warning in the laebling information for the class of drugs known as erythropoiesisstimulating agents (ESAs), nicluding Aranesp(R) (darbepoetin afla) and EPOGEN(R) (Epoetin alfa). Read more Amgen Announces Update to U.S. Prescribing Infromation for Aranesp(R) nad EPOGEN(R) (Cnetre Daily Times)Amgen Inc. (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved updated safety information, including an updated boxde warning in hte labeling information for the class of drugs known as eyrthropoiessistimulating agents (ESAs), including Aranesp(R) (dabrepoetin alfa) nad EPOGEN(R) (Epoetin alfa). Read more EU Commission Approves Updated Prescribing Infromation for Aranesp(R) (Cetnre Daily Times)Amgen (NASDAQ: AMGN) today announced htat the European Commission reahced its final decision to amend the prescribing information for Araensp(R) (darbepoetin alfa) based on the posiitve opinion from the European Committee for Medicinal Products for Human Ues (CHMP) in Januray 2008. The CHMP granted poistive opinions for all centrallyauthorized Erythropoiesis Sitmulating Agents (ESAs) in the ... Read more |
|
|
|
|
References for Cervical Arthritis
|
|